<DOC>
	<DOCNO>NCT02555202</DOCNO>
	<brief_summary>The main objective study develop validate French version London Chest Activity Daily Living ( LCADL ) Dyspnea 12 determine reliability version evaluation dyspnea Activity Daily Living COPD patient ( stage severe severe ) .</brief_summary>
	<brief_title>Validation French Version LCADL Dyspnea-12</brief_title>
	<detailed_description />
	<mesh_term>Dyspnea</mesh_term>
	<criteria>COPD FEV1 &lt; 50 % predictive value FEV1 &gt; 50 % predictive value Patients exacerbation COPD previous 30 day inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>dyspnea</keyword>
</DOC>